Abstract
ObjectivesIntermittent fasting boosts some host defence mechanisms while modulating the inflammatory response. Lower-frequency fasting is associated with greater survival and lower risk from COVID-19-related comorbidities. This study evaluated associations of periodic fasting with COVID-19 severity and, secondarily, initial infection by SARS-CoV-2.DesignProspective longitudinal observational cohort study.SettingSingle-centre secondary care facility in Salt Lake City, Utah, USA with follow-up across a 24-hospital integrated healthcare system.ParticipantsPatients enrolled in the INSPIRE registry in 2013–2020 were studied for the primary outcome if they tested positive for SARS-CoV-2 during March 2020 to February 2021 (n=205) or, for the secondary outcome, if they had any SARS-CoV-2 test result (n=1524).InterventionsNo treatment assignments were made; individuals reported their personal history of routine periodic fasting across their life span.Main outcome measuresA composite of mortality or hospitalisation was the primary outcome and evaluated by Cox regression through February 2021 with multivariable analyses considering 36 covariables. The secondary outcome was whether a patient tested positive for SARS-CoV-2.ResultsSubjects engaging in periodic fasting (n=73, 35.6%) did so for 40.4±20.6 years (max: 81.9 years) prior to COVID-19 diagnosis. The composite outcome occurred in 11.0% of periodic fasters and 28.8% of non-fasters (p=0.013), with HR=0.61 (95% CI 0.42 to 0.90) favouring fasting. Multivariable analyses confirmed this association. Other predictors of hospitalisation/mortality were age, Hispanic ethnicity, prior MI, prior TIA and renal failure, with trends for race, smoking, hyperlipidaemia, coronary disease, diabetes, heart failure and anxiety, but not alcohol use. In secondary analysis, COVID-19 was diagnosed in 14.3% of fasters and 13.0% of non-fasters (p=0.51).ConclusionsRoutine periodic fasting was associated with a lower risk of hospitalisation or mortality in patients with COVID-19. Fasting may be a complementary therapy to vaccination that could provide immune support and hyperinflammation control during and beyond the pandemic.Trial registrationClinicaltrials.gov,NCT02450006(the INSPIRE registry).
Funder
Intermountain Research and Medical Foundation
Dell Loy Hansen Heart Foundation
Subject
Nutrition and Dietetics,Medicine (miscellaneous),Health (social science)
Reference39 articles.
1. Hormone-fuel interrelationships during fasting.
2. Ruderman NB , Aoki TT , Cahill GF . Gluconeogenesis and its disorders in man. In: Hanson RW , Mehlman MA , eds. Gluconeogenesis: its regulation in mammalian species. New York: Wiley, 1976: pp 515–30.
3. Owen OE , Reichard GA , Patel MS . Energy Metabolism in Feasting and Fasting. In: Klachko DM , Anderson RR , Heimberg M , eds. Hormones and energy metabolism. advances in experimental medicine and biology. 111, 1979.
4. Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine N-oxide Changes During 24-hour Water-Only Fasting in the FEELGOOD Trial;Washburn;Nutrients,2019
5. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献